Results 171 to 180 of about 37,448 (215)
Some of the next articles are maybe not open access.

Juvenile systemic scleroderma

Current Rheumatology Reports, 2001
Systemic scleroderma in children is very rare and is considered similar to adult-onset disease. In adults, new etiopathogenetic and therapeutic approaches have emerged in recent years. For instance, it has been shown that microchimerism could play a role in disease pathogenesis and that immunoablation followed by stem cell rescue could be of potential ...
openaire   +2 more sources

Systemic Scleroderma and Pregnancy

1999
Abstract Young women with systemic scleroderma often ask me if it is okay to get pregnant. The answer is that it depends on several factors: the stage of the disease, the medications that are required to control the disease, and the risks that people are willing to take in order to have a child.
openaire   +1 more source

Systemic Scleroderma

Archives of Dermatology, 1997
Objective: To confirm significant improvement of the skin score in systemic sclerosis by treatment with interferon gamma in a larger group of patients and to investigate on a molecular level the influence of interferon gamma on collagen type I messenger RNA expression. Design: Open, noncontrolled multicenter study.
openaire   +1 more source

Systemic Scleroderma

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2013
Systemic scleroderma is a chronic autoimmune disease affecting the skin, internal organs and the musculoskeletal system. The presence of Raynaud phenomenon, anti-nuclear antibodies and pathologic capillaroscopy are early signs of the disease. Limited cutaneous SSc, diffuse cutaneous SSc and SSc-overlap syndromes are the main clinical subtypes ...
openaire   +3 more sources

Scleroderma-Inducing Glycosaminoglycan in the Urine of Patients with Systemic Scleroderma

Dermatologica, 2009
A glycosaminoglycan with scleroderma-inducing effect was isolated and partially purified from the urine of patients with systemic scleroderma. The glycosaminoglycan was an N-sulfated glycosaminoglycuronan and its high total sulfate and 2,5-anhydromannose contents suggest that the glycosaminoglycan is a degradation product of heparin or polysulfated ...
H, Ishikawa   +3 more
openaire   +2 more sources

IMMUNOGLOBULINS IN SYSTEMIC SCLERODERMA

Mayo Clinic Proceedings, 1971
S K, Spencer, R K, Winkelmann
openaire   +2 more sources

Systemic Sclerosis (Scleroderma)

2020
Shervin Assassi, John Varga
openaire   +1 more source

Renal Disease and Systemic Sclerosis: an Update on Scleroderma Renal Crisis

Clinical Reviews in Allergy and Immunology, 2022
Voon Ong   +2 more
exaly  

Systemic sclerosis sine scleroderma in children

Rheumatology, 2022
Biagio Castaldi   +2 more
exaly  

[Systemic scleroderma].

La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1984
The etiology of systemic scleroderma is still unknown. This disease is well individualized by its usual forms, i.e. acrosclerosis and diffuse form, whose features and prognosis differ. The description of new entities has generated further interest, particularly through a different diagnostic and therapeutic approach. No specific biologic or immunologic
openaire   +1 more source

Home - About - Disclaimer - Privacy